Authors
Latest:
Data Aggregation in Specialty PharmacyThe value of big data in health care is realized when raw data are transformed into insights that drive practice change and decision making.
Latest:
Comparative Effectiveness Research: Is "Synchronicity" a Valid Outcome?Efforts to compare strategies for healthcare delivery must evaluate effectiveness in terms of the outcomes that we care about most.
Latest:
Healthcare Costs Associated With Chronic Opioid Use and Fibromayalgia SyndromeWhile fibromyalgia is associated with a small increase in healthcare costs compared with matched controls, chronic opioid use in these patients results in a large increase.
Latest:
Direct and Indirect Cost Burden of Chronic Hepatitis CAn estimation of the direct healthcare and indirect work-loss cost burden of chronic HCV using health insurance claims covering 13 million individuals.
Latest:
Predictors of Response to Anti-Tumor Necrosis Factor Alpha Therapies in Rheumatoid ArthritisMethotrexate >15 mg weekly and adalimumab as first-line therapy were positive predictors of anti-TNF-a response in patients with rheumatoid arthritis.
Latest:
Ohio-based Healthcare Companies Pay $19.5 Million to Settle False Medicare Claims AllegationsWhistleblower suits arise from claims for reimbursement under Medicare, Medicaid, or TRICARE.
Latest:
Highlighting the Risk of Occupational Exposure to Hazardous Drugs in the Health Care SettingThe health care setting has the largest and most diverse array of agents that are hazardous to humans.
Latest:
Taking Care of Transplant Patients: A Look at ModernHEALTHOnce patients receive their new organs, the specialty pharmacy can help them navigate through lifelong, complex transplant therapy. Here's a look at one such program.
Latest:
Pharmacotherapy Timing in Heart Failure and Impact on Healthcare CostsThe findings of a retrospective study suggest that timing of heart failure (HF)-related pharmacotherapy following a HF-related encounter has potential implications on subsequent healthcare costs.
Latest:
Understand the 2025-2026 Flu Vaccine Composition RecommendationsThe only major change is in the included strain of influenza A/H2N2 virus, which has been updated for both the egg-based and the cell- and recombinant-based vaccines.
Latest:
The Beauty of Vitamin A and Drug SpinoffsThe best natural and dietary supplements get turned into drugs. This is what happened to Vitamin A.
Latest:
Study Examines Impact of Alcohol on Health, Drug Interactions in Older WomenFive risk factors increased the likelihood of problematic alcohol consumption in older women.
Latest:
Basal Insulin Therapy in Type 2 Diabetes Management: What the Pharmacist Should KnowGuidance on the use of basal insulins (BI) and insulin pens to enable pharmacists to answer questions regarding the safe and effective use of BI for the management of diabetes.
Latest:
Time Horizon: An Early Career PerspectiveThe time frame concept is an underappreciated through line in most planning efforts.
Latest:
Pharmacists as Providers: The Road to Recognition in Washington StateNational attention in the pharmacy press has focused recently on pharmacists being recognized as providers under federal health programs such as the Medication Modernization Act.
Latest:
Moving Health Care into the Future: Proposal for Pharmacist-led Refill AuthorizationsPharmacist-led refill authorizations are a practical solution to the nation’s health care crisis, helping to improve quality while reducing costs as well as saving physicians’ time.
Latest:
Renal Cell Carcinoma is Treatable and CurableEarly diagnosis, surgery while cancer is confined to kidney are key, but pharmacological agents are used for Stage IV.
Latest:
Easing the Minds of Parents 1 EpiPen at a TimeAllowing school access to epinephrine injectors improves patient care.
Latest:
Immune Checkpoint Inhibitor-Associated Nephritis: A Case of Nivolumab-Induced Acute Kidney Injury in a Patient with Urothelial CarcinomaThis case highlights the importance of recognizing ICPI-AKI, implementing effective therapeutic interventions, and understanding the clinical context to prevent irreversible renal damage.
Latest:
The Appropriateness of Use of 3 Classes of Psychotropic Medications in Children and AdolescentsFor the majority of children and adolescents receiving a psychotropic medication there is a valid medical diagnosis.
Latest:
Cost-Effectiveness of Fingolimod in Treating Patients With Relapsing-Remitting Multiple SclerosisFingolimod, a first-line, once-daily oral disease-modifying therapy for relapsing-remitting multiple sclerosis, has the lowest cost per relapse avoided compared with other first-line agents.
